FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

383711000001107: Methotrexate 2.5mg tablets (Mayne Pharma Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17070501000001116 Methotrexate 2.5mg tablets (Mayne Pharma Plc) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
106087901000001114 Methotrexate 2.5mg tablets (Pfizer Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Methotrexate 2.5mg tablets (Mayne Pharma Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Methotrexate 2.5mg tablets (Mayne Pharma Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Methotrexate 2.5mg tablets (Mayne Pharma Plc) Is a Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Methotrexate 2.5mg tablets (Mayne Pharma Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Methotrexate 2.5mg tablets (Mayne Pharma Plc) Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
Methotrexate 2.5mg tablets (Mayne Pharma Plc) Has active ingredient Methotrexate false Inferred relationship Existential restriction modifier
Methotrexate 2.5mg tablets (Mayne Pharma Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Methotrexate 2.5mg tablets (Mayne Pharma Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Methotrexate 2.5mg tablets (Mayne Pharma Plc) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Methotrexate 2.5mg tablets (Mayne Pharma Plc) Has specific active ingredient Methotrexate true Inferred relationship Existential restriction modifier
Methotrexate 2.5mg tablets (Mayne Pharma Plc) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Methotrexate 2.5mg tablets (Mayne Pharma Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Methotrexate 2.5mg tablets (Mayne Pharma Plc) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Methotrexate 2.5mg tablets (Mayne Pharma Plc) Has excipient Lactose false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Methotrexate 2.5mg tablets (Mayne Pharma Plc) 100 tablet Is pack of False Methotrexate 2.5mg tablets (Mayne Pharma Plc) Inferred relationship Existential restriction modifier
Methotrexate 2.5mg tablets (Mayne Pharma Plc) 100 tablet Has AMP True Methotrexate 2.5mg tablets (Mayne Pharma Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start